trending Market Intelligence /marketintelligence/en/news-insights/trending/Grq3zVYQISEabL8QxMl7zw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Kindred Biosciences plans common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Kindred Biosciences plans common stock offering

Kindred Biosciences Inc. is looking to raise funds for its product pipeline via an underwritten public offering that is yet to be priced.

The San Francisco-based biotechnology company, which is developing medicines for pets, has engaged Barclays Capital Inc. and Stifel as joint book-running managers. The underwriters will have an option to buy additional shares from the company.